Research projects
Cima Universidad de Navarra
-
15 de april de 2021Medicinal ChemistryActive
MicroBiomics: Applications of the multi-omic study of the microbiota to the development of innovative biotechnological solutions in the area of health care.
Cima Principal Investigator: Antonio Pineda LucenaFunded by: Government of Navarra -
15 de april de 2021Non-coding RNA in hepatocarcinoma and other liver diseasesActive
BLANCA Project: Genomic technology to generate a cancer vaccine
Cima Principal Investigator: Mª Purificación Fortes Alonso [SP]Funded by: Government of Navarra. Strategic R&D projects. (GEMA V challenge). -
1 de january de 2021Heart FailureActive
PI20/01319 Identification of a biomarker-based molecular fingerprint of heart failure with chronic kidney disease. Potential mechanistic, prognostic and therapeutic implications
Cima Principal Investigator: Susana Ravassa Albéniz [SP]Funded by: Carlos III Health Institute -
1 de january de 2021Heart FailureActive
Prevalence of cardiac sequelae after SARS-CoV-2 infection. CAR-VID study
Cima Principal Investigator: Begoña López SalazarFunded by: Fundación Francisco Soria-Melguizo -
1 de january de 2021Active
-
1 de january de 2021Heart FailureActive
ICI20/00011 Prospective, multicenter, open-label study to evaluate the efficacy of esmolol in the early identification of cardiovascular disorders induced by cirrhosis, diabetes mellitus and cardiotoxic treatments (bB-ECHO).
Cima Principal Investigator: Arantxa González Miqueo [SP]Funded by: Carlos III Health Institute -
1 de january de 2021Non-Coding RNA and Regulation of the Cancer GenomeActive
Identifying new therapeutic approaches for treatment-resistant bowel cancer
Cima Principal Investigator: Maite HuarteFunded by: Worldwide Cancer Research -
17 de june de 2020Myeloid PathologyActive
AGATA project: Alliance in Advanced Genomics for the development of Personalized Therapies in Navarre
Cima Principal Investigator: Felipe PrósperFunded by: Government of Navarra. Strategic R&D projects, Smart Specialization Strategy S3 framework (GEMA IV challenge). -
17 de june de 2020Active
Leadership and INnovation in cancer immunotherapy from Navarra (LINTERNA)
Funded by: Government of Navarra. Strategic R&D projects, Smart Specialization Strategy S3 framework (GEMA IV challenge). -
1 de may de 2020Computational BiologyActive
2020-2023 Novel methods to elucidate abiraterone resistance mechanisms using RNA-Seq data and xenograft models from CRPC patients
Cima Principal Investigator: Mikel Hernáez ArrazolaFunded by: USA Department of Defense, FY19 DoD CDMRP PCRP